TTP plc (TTP), a leading independent technology and product development company, today announced it has established a partnership with NHS Highland and The University of the Highlands and Islands, to ...

The Institute of Physics recognises an innovative sensor from The Technology Partnership used by Philips Healthcare to help COPD patients TTP has been awarded a prestigious Innovation Award by the ...

X. Long Zheng, MD, PhD, discusses the unmet needs of acquired TTP, and the future of treatment. X. Long Zheng, MD, PhD: What are the unmet needs in acquired TTP [thrombotic thrombocytopenic purpura] ...

MALMÖ, Sweden, Dec. 21, 2016 /PRNewswire/ -- Hansa Medical AB (Nasdaq Stockholm: HMED) today announced that it will not continue its clinical Phase II study with IdeS in acquired TTP. The decision ...

Judicious use of caplacizumab (Cablivi) can reduce the risk of severe bleeding and help manage costs associated with the therapy in patients living with thrombotic thrombocytopenic purpura (TTP). The ...